Free Trial
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 2,550 +25.00 (+0.99%)
As of 08/29/2025 11:19 AM Eastern

About Bioventix Stock (LON:BVXP)

Key Stats

Today's Range
2,500
2,550
50-Day Range
2,300
3,020
52-Week Range
2,199
4,359
Volume
5,554 shs
Average Volume
7,416 shs
Market Capitalization
£133.24 million
P/E Ratio
1,721.58
Dividend Yield
0.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BVXP Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
3 UK Dividend Stocks Offering Yields Up To 7.2%
3 top AIM stocks to consider buying before they recover
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 3,240 on January 1st, 2025. Since then, BVXP shares have decreased by 21.3% and is now trading at GBX 2,550.

Bioventix PLC (LON:BVXP) posted its quarterly earnings data on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share (EPS) for the quarter. Bioventix had a trailing twelve-month return on equity of 69.09% and a net margin of 59.51%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
3/31/2025
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
LON:BVXP
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 1.48
Trailing P/E Ratio
1,721.58
Forward P/E Ratio
15.33
P/E Growth
N/A
Net Income
£8.12 million
Net Margins
59.51%
Pretax Margin
N/A
Return on Equity
69.09%
Return on Assets
54.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.42
Quick Ratio
5.50

Sales & Book Value

Annual Sales
£13.66 million
Price / Sales
9.75
Cash Flow
GBX 82.56 per share
Price / Cash Flow
30.89
Book Value
GBX 229.94 per share
Price / Book
11.09

Miscellaneous

Outstanding Shares
5,225,000
Free Float
N/A
Market Cap
£133.24 million
Optionable
Not Optionable
Beta
0.35
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:BVXP) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners